CTMX
#2817
CytomX Therapeutics, Inc. - Common Stock
2.4 2 USD
-0.06%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-5.84%
Variación mensual
-26.67%
Variación en los últimos 6 meses
-45.00%
Cambio anual
-27.76%
Cierres anteriores
2.5 7
Open
2.5 6
Mínimo
2.4 1
Máximo
2.5 8
Financials
- Market Capitalization 527.32 M
- Employee 69
- Founded 2008
- CEO N/A
- Website www.cytomx.com
- Headquarter Delaware, United States
- FIGI BBG001J472L3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-33.83
Relación precio/flujo de caja
7.71
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2791 |  SGMT Sagimet Biosciences Inc. - Series A Common Stock | 8.80 USD | -1.46% | -2.11% | -19.71% | +17.33% | 547.00 M USD | ||
| 2812 |  PBYI Puma Biotechnology Inc - Common Stock | 10.29 USD | 0.00% | +5.00% | +13.08% | +96.00% | 531.17 M USD | ||
| 2828 |  MNPR Monopar Therapeutics Inc. - Common Stock | 77.05 USD | -2.42% | -0.03% | -31.20% | +41.07% | 517.17 M USD | ||
| 2829 |  VALN Valneva SE - American Depositary Shares | 5.93 USD | +2.60% | -1.82% | -12.28% | -41.92% | 514.55 M USD |